On November 19, 2018 OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of lung cancer, reported that the Company will provide a corporate overview at the Piper Jaffray 30th Annual Health Care Conference, being held November 27-29, 2018 at the Lotte New York Palace Hotel in New York, NY (Press release, Oncocyte, NOV 19, 2018, View Source [SID1234531492]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

OncoCyte Corporation Presentation Details:

Date: Thursday, November 29
Time: 10:00am Eastern Time
Location: Lotte New York Palace Hotel
Webcast: View Source;tp_key=48b258fde4